Adlai Nortye Ltd. American Depositary Shares (ANL)
Largest Insider Buys in Sector
ANL Stock Price History Chart
ANL Stock Performance
About Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule EP4 antagonist to modulate the tumor microenvironment; and AN4005, an oral small-molecule PD-L1 inhibitor to induce and stabilize PD-L1 …
Insider Activity of Adlai Nortye Ltd. American Depositary Shares
Over the last 12 months, insiders at Adlai Nortye Ltd. American Depositary Shares have bought $0 and sold $0 worth of Adlai Nortye Ltd. American Depositary Shares stock.
On average, over the past 5 years, insiders at Adlai Nortye Ltd. American Depositary Shares have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 8,700 shares for transaction amount of $168,717 was made by RHODES THOMAS L (director) on 2004‑09‑27.
List of Insider Buy and Sell Transactions, Adlai Nortye Ltd. American Depositary Shares
| 2006-04-26 | Sale | President and COO | 750 0.029% | $26.95 | $20,213 | |||
| 2006-04-24 | Sale | President and COO | 500 0.0193% | $26.94 | $13,470 | |||
| 2006-04-21 | Sale | President and COO | 500 0.0194% | $27.02 | $13,510 | |||
| 2006-04-20 | Sale | President and COO | 500 0.0193% | $26.95 | $13,475 | |||
| 2006-04-19 | Sale | President and COO | 1,050 0.0408% | $27.05 | $28,405 | |||
| 2006-04-17 | Sale | President and COO | 250 0.0098% | $27.24 | $6,810 | |||
| 2006-04-13 | Sale | President and COO | 250 0.0098% | $27.23 | $6,807 | |||
| 2006-04-12 | Sale | President and COO | 500 0.0197% | $27.46 | $13,728 | |||
| 2006-04-11 | Sale | President and COO | 250 0.0099% | $27.45 | $6,863 | |||
| 2006-03-24 | Sale | President and COO | 800 0.0325% | $28.29 | $22,635 | |||
| 2006-03-23 | Sale | President and COO | 200 0.0081% | $28.31 | $5,662 | |||
| 2006-03-22 | Sale | President and COO | 250 0.0102% | $28.38 | $7,095 | |||
| 2006-03-20 | Sale | President and COO | 2,300 0.0939% | $28.44 | $65,415 | |||
| 2006-03-17 | Sale | President and COO | 2,500 0.1023% | $28.50 | $71,250 | |||
| 2005-01-03 | Sale | director | 7,482 0.2409% | $22.43 | $167,803 | |||
| 2004-09-27 | director | 8,700 0.2422% | $19.39 | $168,717 | ||||
| 2004-09-24 | director | 4,500 0.1256% | $19.44 | $87,494 | ||||
| 2004-09-23 | director | 8,200 0.2281% | $19.38 | $158,883 | ||||
| 2004-09-22 | director | 2,800 0.0774% | $19.25 | $53,897 | ||||
| 2004-09-21 | director | 800 0.022% | $19.13 | $15,305 |